A randomised, active controlled, open-label, 2-way cross-over, multicentre study to investigate the palatability, acceptability, pharmacokinetics, safety and tolerability, and treatment compliance of multidoses of ADV6770 as monotherapy or in combination, in children with childhood absence epilepsy.
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Ethosuximide (Primary) ; Ethosuximide
- Indications Absence epilepsy
- Focus Therapeutic Use
- Acronyms KIEKIDS A11CS
- Sponsors Advicenne
- 04 Oct 2017 New trial record